Newsroom Navigation

Contact Info:
Office of Public Affairs
2000 Circle of Hope,
Salt Lake City, UT 84112

public.affairs@hci.utah.edu

801-587-7639

Recent News

Treating Prostate Cancer: Jeff Metcalf's Story
In The Media, HCI News

Treating Prostate Cancer: Jeff Metcalf's Story

Prostate cancer is the most common cancer among men. In fact, 1 in 8 men will be diagnosed with prostate cancer during their lifetimes. Many patients receive a diagnosis of prostate cancer and immediately begin to imagine difficult and time-consuming radiation treatments, but Huntsman Cancer Institute is pioneering new technology to help these patients and offering them renewed hope for the future.

Read More

When Cancer of Unknown Origin Strikes, Family Members Are At Increased Risk
News, Press Releases

When Cancer of Unknown Origin Strikes, Family Members Are At Increased Risk

Cancer usually begins in one location and then spreads, but in 3-5% of cancer patients, the tissue where a cancer began is unknown. In these individuals a cancer diagnosis is made because it has metastasized to other sites. Patients with these so-called “cancers of unknown primary,” or CUP, have a very poor prognosis, with a median survival of three months. A new study in the Journal of the American Medical Association (JAMA) Oncology finds that family members of CUP patients are at higher risk of developing CUP themselves, as well as cancers of the lung, pancreas, colon, and some cancers of the blood.

Read More

cancer, genetics

Possible New Mechanism for Aspirin’s Role in Cancer Prevention
News, Press Releases

Possible New Mechanism for Aspirin’s Role in Cancer Prevention

Aspirin has been shown to decrease the risk of colorectal cancer and possibly other cancers. However, the risk of side effects, including in some cases severe gastrointestinal bleeding, makes it necessary to better understand the mechanisms by which aspirin acts at low doses before recommending it more generally as a preventative, says Cornelia Ulrich, PhD, Senior Director of Population Sciences at Huntsman Cancer Institute in Salt Lake City.

Read More

A Cancer-Killing Cold Sore Virus Fights Late Stage Melanoma
News, Press Releases

A Cancer-Killing Cold Sore Virus Fights Late Stage Melanoma

The U.S. Food and Drug Administration announced October 27 that it has approved, for the first time, an oncolytic (cancer-killing) viral therapy in the U.S. The drug was approved for use against late stage melanoma, a deadly skin cancer that can be difficult to treat.

Read More

Why Elephants Rarely Get Cancer
News, Press Releases

Why Elephants Rarely Get Cancer

Why elephants rarely get cancer is a mystery that has stumped scientists for decades. A study led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah and Arizona State University, and including researchers from the Ringling Bros. Center for Elephant Conservation, may have found the answer.

Read More

Study Finds Childhood Cancer Survivors More Likely to Be Enrolled in Social Security Support as Adults
News, Press Releases

Study Finds Childhood Cancer Survivors More Likely to Be Enrolled in Social Security Support as Adults

Children with cancer have a good chance of surviving the disease—today more than 80% survive due to advances in treatment and care. However, recent studies have shown that some of these more than 420,000 U.S. childhood cancer survivors face future health related challenges as they become adults such as a second cancer diagnosis, cardiac failure, or other severe medical complications.

Read More

Characterization of the Nutrient Needs of Triple Negative Breast Cancer Leads to the Identification of a Molecular Signature for Cancer Outcomes
News, Press Releases

Characterization of the Nutrient Needs of Triple Negative Breast Cancer Leads to the Identification of a Molecular Signature for Cancer Outcomes

Compared to other types of breast cancer, triple negative breast cancers are often more aggressive and have fewer treatment options. In a new study published in the journal Proceedings of the National Academy of Sciences (PNAS), researchers at Huntsman Cancer Institute and the University of Utah have identified a molecular mechanism that triple negative breast cancer cells use to survive and grow.

Read More

Noted UCSF Scientist Joins Research Team at Huntsman Cancer Institute
News, Press Releases

Noted UCSF Scientist Joins Research Team at Huntsman Cancer Institute

Martin McMahon, Ph.D., joins Huntsman Cancer Institute (HCI) at the University of Utah in August as Professor in the Department of Dermatology and HCI Senior Director of Pre-Clinical Translation. Professor McMahon is currently the Efim Guzik Distinguished Professor of Cancer Biology at the University of California, San Francisco and Assistant Director of Professional Education and Co-leader of the Helen Diller Family Comprehensive Cancer Center (HCFCCC) Developmental Therapeutics Program.

Read More

Cell Mechanism Discovered That May Cause Pancreatic Cancer
News, Press Releases

Cell Mechanism Discovered That May Cause Pancreatic Cancer

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have found that defects in how cells are squeezed out of overcrowded tissue to die, a process called extrusion, may be a mechanism by which pancreatic cancer begins. From these findings, they may have identified an effective way to reverse the defective extrusion’s effects without destroying normal tissues nearby. The results were published in the latest edition of the journal eLife.

Read More

New Study Findings Help Physicians and Patients Determine Prostate Cancer Risk
News, Press Releases

New Study Findings Help Physicians and Patients Determine Prostate Cancer Risk

A discovery by researchers at Huntsman Cancer Institute shows that looking at whether a man’s uncles and great-grandparents, among other second- and third-degree relatives, had prostate cancer could be as important as looking at whether his father had prostate cancer. A more complete family history would give physicians a new tool to decide whether or not a PSA test was appropriate.

Read More

Research on a Rare Cancer Exposes Possible Route to New Treatments
News, Press Releases

Research on a Rare Cancer Exposes Possible Route to New Treatments

Researchers from Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered the unusual role of lactate in the metabolism of alveolar soft part sarcoma (ASPS), a rare, aggressive cancer that primarily affects adolescents and young adults. The study also confirmed that a fusion gene is the cancer-causing agent in this disease. The research results were published online in the journal Cancer Cell November 26.

Read More

childhood cancers

Huntsman Cancer Institute Investigator Recognized Among World's Most Cited Researchers
Awards, Press Releases

Huntsman Cancer Institute Investigator Recognized Among World's Most Cited Researchers

Michael Deininger, MD, PhD, a Huntsman Cancer Institute (HCI) investigator and professor of internal medicine at the University of Utah, has been listed among the world’s Highly Cited Researchers in 2014 by Thomson Reuters, an international media firm. The list includes more than 3,000 authors worldwide in 21 science and social science fields, representing the top 1% of authors most cited in their specialty areas for the years 2002 to 2012.

Read More

Huntsman Cancer Institute Investigator Receives Leadership Award from the National Cancer Institute
Awards, Press Releases

Huntsman Cancer Institute Investigator Receives Leadership Award from the National Cancer Institute

Neeraj Agarwal, MD, a Huntsman Cancer Institute (HCI) investigator and associate professor of medicine at the University of Utah, has received the 2014 Cancer Clinical Investigator Team Leadership Award from the National Cancer Institute (NCI). This highly competitive award recognizes exceptional cancer investigators for contributions to advancing clinical research through collaborative team science.

Read More

Huntsman Cancer Institute Receives Funding to Establish a National Clinical Trials Network Site
News, Awards, Press Releases

Huntsman Cancer Institute Receives Funding to Establish a National Clinical Trials Network Site

A team of physician-researchers from Huntsman Cancer Institute (HCI) at the University of Utah (U of U) will receive nearly $3.6 million over the next five years in a cooperative agreement with the National Institutes of Health (NIH) to establish a Network Lead Academic Participating Site (NLAPS). The award places HCI in an elite group of only 30 to 40 NLAPS locations nationwide; these sites are part of the NIH effort to create a new National Clinical Trials Network (NCTN).

Read More

u0035345

$5,000,000 Gift to Support Advancing Research about Cancers that Affect Women
News, Awards, Press Releases

$5,000,000 Gift to Support Advancing Research about Cancers that Affect Women

Huntsman Cancer Foundation President and CEO, David Huntsman, announced today that the Jon M. Huntsman family and Huntsman Cancer Foundation have made another gift in the amount of $5,000,000 to seed the establishment of a Center of Excellence in Women’s Cancers at Huntsman Cancer Institute (HCI). In announcing the gift, Mr. Huntsman stated, “We understand the importance of striking an appropriate balance between investing in buildings and equipment, and also investing in programs and people at Huntsman Cancer Institute. This gift will support the recruitment of top talent in the cancer field to speed discovery from bench to bedside to benefit mothers, wives, sisters, and daughters.”

Read More


Our media relations representatives are here to help reporters Monday-Friday, 7:30 am-5 pm.

Debby Rogers
Public Affairs Manager
Phone: 801-587-7639
debby.rogers@hci.utah.edu

Amie Parker
Public Relations Associate
Phone: 801-213-5755
amie.parker@hci.utah.edu

Jill Woods
Administrative Assistant
Phone: 801-585-5321
Fax: 801-585-0900
jill.woods@hci.utah.edu

After-hours calls: Reporters calling before or after business hours on an urgent matter can page the University of Utah Health on-call media relations representative at 801-581-7387 and press 1.